ACCU-CHEK® 360° View Tool

when used collaboratively with patients1Proven to lower A1C

accu-chekconnect.com/stepstudy

1 Polonsky WH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262-267. ACCU-CHEK and ACCU-CHEK 360° are trademarks of Roche. © 2011 Roche. 316-50161-0711

The only brand with a proven approach to significantly lower a patient’s A1C1

You’re invited to attend the ACCU-CHEK Product Theater at the AADE 11 Annual Meeting and Exhibition for the following presentation:

STeP in the Right Direction: Discover a Proven Approach to Engage Patients and Improve Outcomes

Wednesday, August 3, 2011South Seas Ballroom 4:00–5:00 PM

Speakers:Deborah Hinnen, RN, ARNP, BC-ADM, CDE, FAAN Davida F. Kruger, MSN, APN-BC, BC-ADM

Sponsored by Roche

We look forward to seeing you at Booth 1925!